62 related articles for article (PubMed ID: 15892261)
21. A new antitumor nucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), is a potent inhibitor of RNA synthesis.
Matsuda A; Fukushima M; Wataya Y; Sasaki T
Nucleosides Nucleotides; 1999; 18(4-5):811-4. PubMed ID: 10432683
[TBL] [Abstract][Full Text] [Related]
22. Preparation of 1-(3-C-(propa-1,2-dienyl)-D-ribo-pentofuranosyl)uracil, an allenic nucleoside.
Dauvergne J; Burger A; Biellmann JF
Nucleosides Nucleotides Nucleic Acids; 2001; 20(10-11):1775-81. PubMed ID: 11719991
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of branched and conformationally restricted analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
Hrdlicka PJ; Andersen NK; Jepsen JS; Hansen FG; Haselmann KF; Nielsen C; Wengel J
Bioorg Med Chem; 2005 Apr; 13(7):2597-621. PubMed ID: 15755661
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic mechanisms of inhibitor of RNA synthesis, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106).
Yokogawa T; Takenaka K; Ogawa D; Futagami M; Matsuda A; Fukushima M; Kitade Y; Wataya Y
Nucleic Acids Symp Ser; 2000; (44):193-4. PubMed ID: 12903334
[TBL] [Abstract][Full Text] [Related]
25. 1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), a novel potent inhibitor of RNA polymerase, potentiates the cytotoxicity of CDDP in human cancer cells both in vitro and in vivo.
Kazuno H; Fujioka A; Fukushima M; Wataya Y; Matsuda A; Sasaki T
Int J Oncol; 2009 May; 34(5):1373-80. PubMed ID: 19360349
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the antitumor activity of 1-(3-C-ethynyl-beta-D-ribofuranosyl) (PJ272), a recent ribonucleoside analogue.
Holl V; Jung P; Weltin D; Dauvergne J; Burger A; Coelho D; Dufour P; Aubertin AM; Bischoff PL; Biellmann JF
Anticancer Res; 2000; 20(3A):1739-42. PubMed ID: 10928102
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity.
Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR
Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145
[TBL] [Abstract][Full Text] [Related]
28. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
Chandrasekaran B; Capizzi RL; Kute TE; Morgan T; Dimling J
Cancer Res; 1989 Jun; 49(12):3259-66. PubMed ID: 2720678
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
Matsumoto SS; Yu J; Yu AL
J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
[TBL] [Abstract][Full Text] [Related]
30. Sequential irreversible, actinomycin D-sensitive, and cycloheximide-sensitive steps prior to cortisol inhibition of uridine utilization by P1798 tumor lymphocytes.
Stevens J; Stevens YW
Cancer Res; 1975 Aug; 35(8):2145-53. PubMed ID: 1149029
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of the inhibitory effect of 11 beta-hydroxypregna-1, 4-diene-3, 20-dione (delta HOP) at high concentrations in RNA synthesis.
González MD; Rondinone CM; Burton G; Lantos CP; Roldán A
Acta Physiol Pharmacol Latinoam; 1986; 36(3):303-12. PubMed ID: 2437767
[TBL] [Abstract][Full Text] [Related]
32. A novel apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis--the possibility of RNase L activated pathway as a target of ECyd.
Naito T; Yokogawa T; Kim HS; Matsuda A; Sasaki T; Fukushima M; Kitade Y; Wataya Y
Nucleic Acids Symp Ser (Oxf); 2007; (51):435-6. PubMed ID: 18029773
[TBL] [Abstract][Full Text] [Related]
33. The mechanisms of inhibitory effects of liver extract on lymphocyte proliferation: II. Inhibition of DNA, RNA, and protein synthesis and their relationship to the effects of metabolic inhibitors.
Su HL; Huang MH; Yu CL; Han SH; Chiang BN; Wang SR
Clin Exp Immunol; 1988 May; 72(2):228-32. PubMed ID: 2457463
[TBL] [Abstract][Full Text] [Related]
34. RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I.
Buckwalter CA; Lin AH; Tanizawa A; Pommier YG; Cheng YC; Kaufmann SH
Cancer Res; 1996 Apr; 56(7):1674-81. PubMed ID: 8603419
[TBL] [Abstract][Full Text] [Related]
35. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
[TBL] [Abstract][Full Text] [Related]
36. Effect of bleomycin on DNA, RNA, protein, chromatin and on cell transformation by oncogenic RNA viruses.
Müller WE; Zahn RK
Prog Biochem Pharmacol; 1976; 11():28-47. PubMed ID: 63969
[TBL] [Abstract][Full Text] [Related]
37. Mouse preimplantation embryo development in vitro: effect of sodium concentration in culture media on RNA synthesis and accumulation and gene expression.
Ho Y; Doherty AS; Schultz RM
Mol Reprod Dev; 1994 Jun; 38(2):131-41. PubMed ID: 7521650
[TBL] [Abstract][Full Text] [Related]
38. Radioautographic comparison of RNA synthesis patterns in the epithelial cells of mouse pyloric antrum following 3H-uridine and 3H-orotic acid injections.
Bissonnette R; Leblond CP; Lee ER; Paiement J
Am J Anat; 1987 Nov; 180(3):209-25. PubMed ID: 2449065
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic mechanism of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd).
Wataya Y; Takenaka K; Yokogawa T; Matsuda A; Sasaki T; Fukushima M
Nucleic Acids Symp Ser; 1999; (42):133-4. PubMed ID: 10780415
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd).
Hrdlicka PJ; Jepsen JS; Wengel J
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):397-400. PubMed ID: 16247958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
